skip to main content

Cardiology — EECC MCQ

Instant feedback + full explanation. One question, done properly.

HardCoronary RevascularizationCardiologyEECC

A 63-year-old with ACS DES 9 months ago has high bleeding risk and no recurrent ischemia. Consideration for DAPT de-escalation?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: A — Transition to single antiplatelet therapy may be reasonable at 6 months in HBR

In high bleeding risk patients after ACS PCI, shortening DAPT to 6 months can be considered if clinically stable. Universal 12-24 months is not required in HBR. Stopping all antiplatelets is unsafe. Anticoagulants are not substitutes for DAPT.

Reference: shortening DAPT to 6 months can be considered if clinically stable. Universal 12-24 months is not required in HBR. Stopping all antiplatelets is unsafe. Anticoagulants are not substitutes for DAPT."